Yinfeng Chen | Medicine | Women Researcher Award

Posted on by Forensic Scientist

Ms. Yinfeng Chen | Medicine | Women Researcher Award

Attending physician | Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University | China

Dr. Yinfeng Chen is an attending physician at the Department of Nephrology, Hangzhou TCM Hospital, affiliated with Zhejiang Chinese Medical University. With over a decade of experience in clinical nephropathy, Dr. Chen has become a recognized expert in the field. She has actively contributed to various academic endeavors and plans to further her research at the Clinical Research Institute of China-Japan Friendship Hospital in 2024. Her expertise lies in kidney diseases, and she is dedicated to providing innovative treatments to improve patient outcomes.

Profile🔍

Scopus

Strengths for the Awards

  • Solid Academic and Professional Background: Yinfeng holds a postgraduate degree in clinical nephropathy from Zhejiang Chinese Medicine University and has 10 years of clinical experience. This provides a solid foundation for her work in the nephrology field.
  • Research Contributions: She has conducted significant research on chronic kidney disease and its correlation with conditions like stroke, diabetic kidney disease, FSGS, and chronic kidney failure. Her work contributes directly to improving patient outcomes and advancing the field of nephrology.
  • Clinical Application and Innovation: Her commitment to providing personalized treatment plans based on individual conditions demonstrates a practical approach to her research, enhancing the impact of her findings on real-world patient care.
  • Active Participation in Academic Activities: She is engaged in further research at the Clinical Research Institute of China-Japan Friendship Hospital, highlighting her dedication to continuous professional development and collaboration.
  • Published Research: Her research has been published in reputable journals (doi: 10.1080/0886022X.2025.2452219), contributing to the academic discourse in the nephrology field.
  • Yinfeng Chen has demonstrated considerable strength in her clinical and research endeavors, particularly in the area of nephrology. Her dedication to improving patient care and advancing the understanding of kidney diseases makes her a strong candidate for the “Women Researcher Award.” With further contributions in publications, patents, or leadership roles in academic organizations, her profile could become even more competitive.

Education 📚

Dr. Chen graduated from Zhejiang Chinese Medicine University with a postgraduate degree in clinical nephropathy. She has since accumulated substantial clinical experience, working in the nephrology department for over 10 years. Her academic journey has continuously been complemented by active participation in academic and research activities.

Experience💼

As an attending physician in nephrology, Dr. Yinfeng Chen has developed tailored treatment plans for patients, particularly in chronic kidney disease (CKD) and diabetic kidney disease. Her decade-long clinical experience has been enriched through various collaborations, including her upcoming research at the Clinical Research Institute of China-Japan Friendship Hospital.

Research Interest On Medicine 🔬

Dr. Chen’s research interests primarily focus on kidney diseases, including chronic kidney disease, stroke, diabetic kidney disease, and FSGS (focal segmental glomerulosclerosis). She has been exploring the correlation between chronic kidney disease and stroke, among other critical issues in nephrology, with a commitment to developing innovative therapies for better patient survival and treatment outcomes.

Awards🏆

Dr. Yinfeng Chen has been nominated for the prestigious “Women Researcher Award,” a recognition of her significant contributions to nephrology and medical research. Her dedication to enhancing kidney disease treatments through her research and clinical expertise makes her an ideal candidate for this award.

Publications📖

Dr. Chen has published several studies in prominent journals. One of her recent articles, titled “Correlation Between Chronic Kidney Disease and Stroke,” was published in the International Journal of Nephrology and Renovascular Disease in 2025. The article can be accessed here. Her work is also cited by numerous other research studies.

Conclusion🌱

With a proven track record in clinical nephrology and an unwavering commitment to advancing kidney disease research, Dr. Yinfeng Chen continues to make significant strides in the field. Her upcoming work and future endeavors promise to further improve kidney disease management and treatment.

Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Posted on by Forensic Scientist

Dr. Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Epidemiologist | Pfizer UK Ltd | United Kingdom

Dr. Andrew Vyse is a seasoned epidemiologist with extensive experience in both the pharmaceutical industry and public health research. He specializes in vaccine-preventable and potentially vaccine-preventable infections, contributing significantly to the field with over 80 peer-reviewed publications.

Profile

Scopus

Strengths for the Awards

  • Prolific Research Contributions:
    • Dr. Vyse has authored over 80 peer-reviewed publications, which demonstrates a consistent and significant contribution to epidemiological research, particularly in the area of vaccine-preventable diseases.
    • Recent publications cover diverse, critical topics such as Lyme disease, pneumococcal vaccination, RSV, and cost-effectiveness of vaccine strategies. This breadth indicates a comprehensive understanding of the field.
  • Impact on Public Health:
    • His work in vaccine-preventable diseases directly contributes to public health improvements, including informing vaccination strategies and addressing vaccine-preventable hospitalizations.
  • Industry and Academic Experience:
    • A balance of pharmaceutical industry experience (Pfizer and GSK) and public health research (UKHSA) highlights his ability to bridge scientific research with practical applications.
    • This unique positioning allows him to contribute to both policy-making and the development of new vaccine technologies.

Education 🎓

Dr. Vyse holds a PhD and MSc, reflecting his robust academic foundation in epidemiology and public health. His educational background has equipped him with the expertise to drive impactful research and clinical applications in his field.

Professional Experience 💼

  • Feb 2017 – Present: Clinical Epidemiologist at Pfizer UK Ltd, supporting the UK Medical Team and global Scientific Affairs for vaccines including pneumococcal, RSV, COVID, meningococcal, and a candidate Lyme vaccine.
  • Jan 2009 – Jan 2017: Global Epidemiologist at GSK Vaccines, contributing to portfolios for meningococcal, DTP, and rotavirus vaccines.
  • May 1993 – Dec 2008: Clinical Scientist at the UK Health Security Agency (formerly Public Health England), focusing on surveillance and epidemiological research for vaccine-preventable infections.

Research Interests On Medicine 🧬

Dr. Vyse’s research interests revolve around vaccine-preventable diseases, with a particular focus on respiratory infections, Lyme borreliosis, and strategies to optimize vaccination coverage in vulnerable populations.

Awards and Recognition 🏆

Dr. Vyse has been recognized for his contributions to epidemiology and vaccine research. His work has garnered significant academic and industry accolades, reflecting his impact on public health initiatives and vaccine development.

Publications 🔖

1. Estimating adult accident and emergency attendances in English hospitals attributed to respiratory syncytial virus

  • Authors: Vyse, A., Wright, H., Begier, E.
  • Year: 2024
  • Citations: 0

2. Using Catalytic Models to Interpret Age-Stratified Lyme Borreliosis Seroprevalence Data

  • Authors: Vyse, A., Colby, E.
  • Year: 2024
  • Citations: 0

3. Incidence of symptomatic Lyme borreliosis in nine European countries

  • Authors: Angulo, F.J., Colby, E., Lebech, A.-M., Moïsi, J.C., Stark, J.H.
  • Year: 2024
  • Citations: 1

4. Adult risk groups for vaccine-preventable respiratory infections: an overview of the UK environment

  • Authors: Reynard, C., Campling, J., Gordon, A.L., Wright, H., Ellsbury, G.
  • Year: 2024
  • Citations: 0

5. Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom

  • Authors: Wilson, M., Lucas, A., Mendes, D., Ellsbury, G.F., Perdrizet, J.
  • Year: 2023
  • Citations: 9

6. Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK

  • Authors: Schley, K., Kowalik, J.C., Sullivan, S.M., Tichy, E., Findlow, J.
  • Year: 2023
  • Citations: 0

7. Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?

  • Authors: Neri, M., Brassel, S., Schirrmacher, H., Steuten, L., Hamson, E.
  • Year: 2023
  • Citations: 4

8. A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019

  • Authors: Paradowska-Stankiewicz, I., Zbrzezniak, J., Skufca, J., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 5

9. Incidence of Lyme Borreliosis in Germany

  • Authors: Skufca, J., Tran, T.M.P., Brestrich, G., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 2

10. Incidence of Lyme Borreliosis in the Dutch General Practice Population

  • Authors: Houben, E., De Jong, H., Penning-Van Beest, F., Herings, R., Stark, J.H.
  • Year: 2023
  • Citations: 3

Conclusion 🌐

Dr. Andrew Vyse’s work bridges the pharmaceutical industry and public health research, driving innovations in vaccine development and disease prevention. His dedication to epidemiology continues to advance global health outcomes, underpinned by his extensive research, impactful publications, and commitment to public health initiatives.